CHARLENE HOOVER: Open Payments
NPI 1104092964 · CATOOSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,886 in 73 payments from 19 companies in 2025. Trend: 2023 $68 · 2024 $1,024 · 2025 $1,886
Food & beverage: $1,886
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $271 |
| PFIZER INC. | 6 | $263 |
| ABBVIE INC. | 16 | $238 |
| Novo Nordisk Inc | 7 | $223 |
| Lilly USA, LLC | 5 | $171 |
| Amgen Inc. | 5 | $171 |
| Paratek Pharmaceuticals, Inc. | 2 | $118 |
| Abbott Laboratories | 3 | $61 |
| Corium, LLC | 5 | $61 |
| Antares Pharma, Inc. | 3 | $50 |
Products named: AIRSUPRA, NURTEC ODT, Wegovy, ZEPBOUND, NUZYRA, QULIPTA, REPATHA, VRAYLAR.
Industry payments across OK — which companies pay providers there.
